Read More Pharma Industry News Harmony’s next growth engine takes shape as BP-205 clears its first clinical test BP-205 shows a 25-hour half-life as Harmony uses record WAKIX revenue to fund its next neuroscience growth engine amid rising orexin competition bySoujanya RaviAugust 7, 2026